Who owns 90041T958 - TURNING POINT THERAPEUTICS I - COM - Put based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

TURNING POINT THERAPEUTICS I - COM - Put Institutional Ownership

Q: What is CUSIP 90041T958?

CUSIP 90041T958 is the security identifier used in SEC filing datasets for 90041T958 - TURNING POINT THERAPEUTICS I - COM - Put.

CUSIP: 90041T958

13F Institutional Holders and Ownership History from Q2 2020 to Q3 2022

Type / Class: Equity / COM

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 90041T958?
CUSIP 90041T958 identifies 90041T958 - TURNING POINT THERAPEUTICS I - COM - Put in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 90041T958:

Q3 2022 (0 holders) Q2 2022 (0 holders) Q3 2021 (0 holders) Q2 2021 (0 holders) Q1 2021 (1 holder) Q4 2020 (0 holders) Q3 2020 (0 holders) Q2 2020 (0 holders)

Institutional Holders of TURNING POINT THERAPEUTICS I - COM - Put across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Price (Median)	Investors
2022 Q3				$0		0
2022 Q2				$4,252,000	$75.27	0
2021 Q3				$0		0
2021 Q2	0	$0	-$861,000	$8,000	$80.00	0
2021 Q1	700	$861,000	+$861,000		$1230.00	1
2020 Q4				$0		0
2020 Q3				$17,000	$85.00	0
2020 Q2				$6,000	$60.00	0